V009-1511 Screening compound: 1-(diphenylmethyl)-4-[3-({3-[(3-methoxyphenyl)methyl]-1,2,4-thiadiazol-5-yl}oxy)benzoyl]piperazine

V009-1511 Screening compound: 1-(diphenylmethyl)-4-[3-({3-[(3-methoxyphenyl)methyl]-1,2,4-thiadiazol-5-yl}oxy)benzoyl]piperazine
V009-1511 Screening compound: 1-(diphenylmethyl)-4-[3-({3-[(3-methoxyphenyl)methyl]-1,2,4-thiadiazol-5-yl}oxy)benzoyl]piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound V009-1511
1-(diphenylmethyl)-4-[3-({3-[(3-methoxyphenyl)methyl]-1,2,4-thiadiazol-5-yl}oxy)benzoyl]piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V009-1511

Molecular Formula

C34H32N4O3S (C34 H32 N4 O3 S)

Compound Name

1-(diphenylmethyl)-4-[3-({3-[(3-methoxyphenyl)methyl]-1,2,4-thiadiazol-5-yl}oxy)benzoyl]piperazine

IUPAC name

1-(diphenylmethyl)-4-[3-({3-[(3-methoxyphenyl)methyl]-124-thiadiazol-5-yl}oxy)benzoyl]piperazine

SMILES

COc1cccc(Cc2nsc(Oc3cc(C(N(CC4)CCN4C(c4ccccc4)c4ccccc4)=O)ccc3)n2)c1

InChI

InChI=1S/C34H32N4O3S/c1-40-29-16-8-10-25(22-29)23-31-35-34(42-36-31)41-30-17-9-15-28(24-30)33(39)38-20-18-37(19-21-38)32(26-11-4-2-5-12-26)27-13-6-3-7-14-27/h2-17,22,24,32H,18-21,23H2,1H3

InChI Key

YSWMGFDDBFLFDB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19764279

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

576.72

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

6.470

Distribution Coefficient, logD

6.469

Water Solubility, LogSw

-5.75

Polar Surface Area

57.066

Acid Dissociation Constant (pKa)

25.05

Base Dissociation Constant (pKb)

4.97

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.60

V009-1511 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

DGK Inhibitors Library (10558 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V009-1511 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V009-1511?
Check Price and Availability of V009-1511, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V009-1511 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V009-1511
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V009-1511
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V009-1511 available by request